KARY ELDRED - 21 Jul 2025 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director
Signature
Jack W. Callicutt, by power of attorney
Issuer symbol
GALT
Transactions as of
21 Jul 2025
Net transactions value
+$2,925
Form type
4
Filing time
22 Jul 2025, 07:36:26 UTC
Previous filing
27 Jan 2025
Next filing
23 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ELDRED KARY Director C/O GALECTIN THERAPEUTICS INC., 4960 PEACHTREE INDUSTRIAL BLVD., STE 240, NORCROSS Jack W. Callicutt, by power of attorney 22 Jul 2025 0001543425

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Purchase $2,925 +1,000 +1.6% $2.92 64,682 21 Jul 2025 Direct
holding GALT Common Stock 2,425 21 Jul 2025 as UTMA custodian for minor child F1
holding GALT Common Stock 2,000 21 Jul 2025 held in trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purpose of Section 16 or for any other purpose.
F2 These shares are held in a special needs trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.